From 1 November 2025 every general practice will benefit from expanded eligibility for MBS bulk billing incentives to all Australians with a Medicare card.
The expanded eligibility of the existing MBS bulk billing incentive to all Australians means that current bulk billing incentives payable to practices that bulk bill children under 16 years of age and patients with a Commonwealth concession card will expand to include all Australians with a Medicare card.
Additionally, from 1 November practices will be able to choose if they wish to participate in the new bulk billing practice incentive program.
New information on both of these bulk billing measures is now available on the Department of Health and Aged Care website including frequently asked questions, and details on eligible MBS services.
Information about the new Bulk Billing Practice Incentive Program
Practices participating in the new Bulk Billing Practice Incentive Program (the Program) will receive an additional 12.5% incentive payment on every $1 of MBS benefit earned from eligible services, split between the GP and the practice.
Participating practices must bulk bill every eligible service for every patient, to receive the incentive payment. This incentive payment will be in addition to MBS Benefits paid (including bulk billing incentives).
To participate in the Program, practices will need to:
To register in the Program, practices will need to:
General Practices can register to participate in the Program from 1 November 2025.
Accredited practices can prepare in advance, by registering for MyMedicare now. Instructions on how to register for MyMedicare are available on the Services Australia Health Professional Education Resources website.
For further general support on MyMedicare or the General Practice Aged Care Incentive (GPACI), please contact CESPHNs Practice Support Team at practicesupport@cesphn.com.au
Health Referral Forms
Immunisation Weekly Update: New vaccination resources released Immunisation Handbook chapters updated Pharmacist Vaccination Standards updated Mpox disinformation corrected by experts New report on COVID-19 health impacts History of immunisation in Australia resource updated New vaccination resources released NSW Health Influenza Prompt Pack NSW Health has released their Influenza Vaccination Prompt…
Immunisation Weekly Update: Updates to NSW Pharmacist Vaccination Standards Free ‘RSV Protection for Infants’ modules Updated vaccine co-administration resource Report Q fever vaccination records before 30 June Flu vaccine orders and updates Your experience matters: Have your say on vaccine storage Respiratory Surveillance Report Updates to NSW Pharmacist Vaccination Standards…
Immunisation Weekly Update: NIP flu vaccine orders open National measles warning Catch-up measles vaccinations Vaccination coverage rates against measles Measles alert for Inner West Sydney NIP flu vaccine orders open Ordering of NIP flu vaccines is now open via the State Vaccine Centre. Approximate delivery time from ordering is 2-3…
Immunisation Weekly Update: Childhood vaccination parent interviews Measles situation in Australia Flu vaccination messaging Flu vaccine QI activities Updated Handbook flu chapter Maternal RSV resources Vaccines in pharmacy Childhood vaccination parent interviews Findings from a recent National Vaccination Insights project survey has shed light on real-life challenges and experiences influencing timely, complete…
Immunisation Weekly Update: School holidays – Immunisation checks prior to travel Global measles outbreak – Free catch-up MMR vaccines for everyone under 60 years Measles alert for Eastern Suburbs SKAI – discussing maternal RSV vaccination COVID-19 resources – New and updated AusVaxSafety’s 2025 flu vaccine surveillance begins Education In case…
Immunisation Weekly Update: Expansion of infant Beyfortus™ (nirsevimab) eligibility Abrysvo® shelf-life extension ATAGI statement on administration COVID-19 vaccines 2025 Measles warning amid rise in global cases Free Pneumococcal SMS recall program Vaccine co-administration guidelines Free education module: RSV protection for infants Expansion of infant Beyfortus™ (nirsevimab) eligibility Eligibility criteria On…
